Matthew Neal

Matthew is a Partner at 5654.

Matthew leads the Health and Life Sciences practice. He is a strategic healthcare communications and investor relations expert. He has advised listed and private companies across their financial and corporate communications strategies, M&A, activism and crisis communications. Matthew has a particular interest in supporting innovative companies achieve their corporate objectives with industry, financial and political stakeholders.

Previously, he was a founding member of Consilium Strategic Communications which grew into Europe’s leading strategic healthcare communications agency. Matthew has worked with businesses across pharma, biotech, medtech, healthtech, healthcare services, investors and industry organisations.